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Abstract
Background: Random samples of 50-year-old men living in Gothenburg have been examined
every 10th year since 1963 with a focus on cardiovascular risk factors. The aims of the study were
to acquire up-to-date information about risk factors in the fifth cohort of 50-year-old men and
women, to re-examine those who were 50 years of age in 1993, and to analyse the prevalence of
the metabolic syndrome (MetSyn) using different definitions.
Methods: A random sample of men and women born in 1953 were examined in 2003–2004 for
cardiovascular risk factors. Men born in 1943 and that participated in the examination in 1993 were
also invited. Descriptive statistics were calculated.
Results: The participation rate among men and women born in 1953 was 60 and 67% respectively.
Among men born in 1943, the participation rate was 87%. The prevalence of obesity was from 15
to 17% (body mass index, BMI ≥ 30) in the three samples. The prevalence of known diabetes was
4% among the 50-year-old men and 6% among the 60-year-old men, and 2% among the women.
Increased fasting plasma glucose varied substantially from 4 to 33% depending on cut-off level and
gender. Mean cholesterol was 5.4 to 5.5 mmol/l. Smoking was more common among women aged
50 (26%) than among men aged 50 (22%) and 60 years (15%). The prevalence of the MetSyn varied
with the definition used: from 10 to 15.8% among the women, from 16.1 to 26% among 50-year-
old men, and from 19.9 to 35% among the 60-year-old men. Only 5% of the men and women had
no risk factors.
Conclusion: This study provides up-to-date information about the prevalence of cardiovascular
risk factors and the MetSyn in middle-aged Swedish men and women. Different definitions of the
MetSyn create confusion regarding which definition to use.
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Background
Since the landmark Framingham Heart study in 1948 [1],
there have been several hundred prospective cohort stud-
ies on cardiovascular disease and associated risk factors.
In Gothenburg the first cohort of 50-year-old men (the
Study of Men Born in 1913) was examined in 1963 [2].
Younger cohorts of 50-year-old men (i.e. men born in
1923, 1933, and 1943) have later been examined every
10th year [3-5].
The present study adds new data by including the 5th
cohort of 50-year-old men (men born in 1953). We have
also examined 50-year-old women (born in 1953) in
addition to a follow-up examination of the 4th cohort of
50-year-old men (born in 1943), now aged 60 years.
With an increasing prevalence of excess body weight and
obesity in the population, the metabolic syndrome (Met-
Syn) has attracted considerable attention during the past
decade as an important risk factor in cardiovascular dis-
ease. There are at least five definitions of Metsyn [6],
which create considerable confusion regarding which def-
inition to use. Furthermore, with so many definitions, it is
difficult to obtain consistent research results.
The aim of the present study was twofold: (1) to acquire
current information about risk factors in cardiovascular
disease in a middle-aged Swedish population and (2) to
analyse the prevalence of the MetSyn using three popular
definitions.
Methods
Participants
The study population consists of three cohorts: one third
of all men (n = 993) and women (n = 994) born in 1953
and living in Gothenburg in 2003 were randomly sam-
pled from the population register and invited to the exam-
ination. Gothenburg, which is a maritime and industrial
city on the West coast of Sweden, is the second largest city
in Sweden with approximately 450,000 inhabitants. The
third cohort, men born in 1943, was a random sample in
1993 and now consists of all persons who were examined
in 1993 (n = 798, 55% of those invited), except for those
individuals that had died (n = 34) or moved abroad (n =
15). This leaves 749 men, now aged 60 years that were
invited to participate in the present study. Based on those
individuals examined, the participation rate was 60%
(595 of 993) among men born in 1953, 67% (667 of 994)
among women born in 1953 and 87% (655 of 749)
among men born in 1943.
Examination procedures
The examinations took place between August 2003 and
December 2004. All participants were mailed a question-
naire on smoking habits and physical activity during lei-
sure time. Each item was rated on a scale from 1 to 4,
where 1 = no physical activity, 2 = moderate activity (e.g.
walking, riding a bicycle and light gardening) for a mini-
mum of 4 hours per week, 3 = regular, strenuous activity
for a minimum of 3 hours per week and 4 = athletic train-
ing (competitive sports regularly). Regular smoking was
defined as smoking at least one cigarette per day. Ex-
smokers were defined as having quit smoking at least one
month before they mailed the questionnaire. A snuff taker
(snuffer) is a person who uses snuff (wet tobacco) daily.
The participants also answered questions about chest
pain, psychological stress, family history of cardiovascular
disease and cancer (parents and siblings), previous and
current medical history and ongoing medication. Psycho-
logical stress was rated on a six-point scale with 0 = no
stress, (1–3 = various grades of intermediate stress), 4 =
continuous stress during the past year and 5 = continuous
stress during the past 5 years. Diabetes was defined as hav-
ing a physician's diagnosis of diabetes. Hypertension was
defined as a physician's diagnosis and/or systolic blood
pressure ≥ 140 and/or diastolic blood pressure (phase 5)
≥ 90 (physician measurement) and/or treatment for
hypertension. Individuals who returned the questionnaire
were invited to the examination, which was performed in
the morning after an overnight fast. One reminder was
sent out to the participants who did not return the first
questionnaire but after that no further action was taken.
The results are based solely on those persons that were
examined.
The study was done in the morning. The participants were
asked to fast overnight. A question relating to when they
had last eaten revealed that close to 90% had complied
with the request to fast. A study nurse measured height
(cm) and weight (kg) with indoor clothing and without
shoes. Waist circumference was measured at the level of
the umbilicus (cm) and hip circumference at the level of
the anterior iliac crest (cm) with the participant standing
and breathing normally. After five minutes of rest, blood
pressure was measured automatically in the right arm in
the seated position with the OMRON 711 monitor. A 12-
lead electrocardiogram was recorded with the participant
relaxed and supine. Blood samples (fasting state) were
taken for analysis of plasma glucose, serum total choles-
terol, high-density lipoprotein (HDL) cholesterol and
serum triglycerides (standard methods at the accredited
university hospital laboratory in Gothenburg). During
2002, the analysis equipment at the laboratory was
upgraded from Hitachi 917 Roche to Modular Roche,
which resulted in an 11% increase of the mean HDL cho-
lesterol levels [Flenner E, personal communication]. Low-
density lipoprotein (LDL) cholesterol was calculatedBMC Public Health 2008, 8:403 http://www.biomedcentral.com/1471-2458/8/403
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using the Friedewald formula [7]. Blood samples were fro-
zen (-70°C) until further analysis.
After the first part of the study was completed, the partici-
pants were served a light breakfast. During breakfast, they
completed another questionnaire on social and psychoso-
cial factors, social network [8], education, working times,
various complaints, sleeping habits and self-ratings on a
seven-point scale regarding their health, economy, family
situation, memory, energy, sleep, ability to handle stress,
and simultaneous capacity [9].
A physician administered a structured interview after
breakfast. The same physician also checked the question-
naires. The physician measured blood pressure using
exactly the same method as in 1963 [2], i.e. with a mer-
cury sphygmomanometer (cuff size 12 × 23 cm) in the
right arm after five minutes of rest with the participant in
the seated position. If potential medical problems were
identified, the participants were referred for further work-
up (severe hypertension, chest pain or other alarming
symptoms). All participants received a letter with the
results from the examination and, if needed, advice about
lifestyle changes.
The review board of the Ethics Committee at the Univer-
sity of Gothenburg approved the study. All participants
signed a written informed consent form.
Statistical methods
The analyses were conducted using the SAS statistical soft-
ware package [10]. Descriptive statistics were used. The
prevalence of the MetSyn was calculated based on three
definitions recently reported in the literature (Table 1).
Results
Demographic data
Demographic data are shown in Table 2. Higher educa-
tion (university/college) was most common among the
50-year-old women. A higher proportion of the 50-year-
olds (men and women) were born abroad (23%) as com-
pared with the 60-year-old men (16%).
Self-reported diseases and family history
In one of the questionnaires the participants were asked
about various common diseases (Table 2). Cardiovascular
diseases and intervention procedures were more com-
monly reported by the 60-year-old men than by the 50-
year-old men and women. Between 36 and 38% of the
participants reported a family history of myocardial inf-
arction, 25–27% reported a family history of stroke, and
23–25% reported a family history of diabetes.
Anthropometric measurements
Details on anthropometric variables are given in Table 3.
The prevalence of obesity (Body mass index [BMI] ≥ 30
kg/m2) was 15% among 50-year-old men and women and
slightly higher (16.6%) among 60-year-old men. Using
the WHO cut-off for waist/hip ratio (>0.85 for women,
>0.90 for men, ref. 11), 38% of the women and 73% of
the 50-year-old men and 79% of the 60-year-old men had
abdominal obesity. Using the AHA criteria (Table 1, ref. 6,
only waist circumference), 30% of the women and 22 and
30% respectively of the 50- and 60-year-old men had
abdominal obesity. Using the International Diabetes Fed-
eration (IDF) criteria (Table 1, only waist circumference)
the corresponding figures for women and men were 56%
and 51–61% respectively.
Table 1: Three definitions of the metabolic syndrome.
NCEP 2001, ref 12 AHA 2005, ref 6 IDF 2005, ref 13
At least 3 of the following: At least 3 of the following: Waist circumference (Euripides) ≥ 94 cm 
(men), ≥ 80 cm (women) plus any 2 of the 
following:
1. Fasting P-glucose ≥ 6.1 mmol/l (≥ 110 mg/dl) 1. Fasting P-glucose ≥ 5.6 mmol/l (≥ 100 mg/dl) 
or drug treatment for elevated glucose.
1. Fasting p-glucose ≥ 5.6 mmol/l (≥ 100 mg/dl) 
or known type 2 diabetes
2. Blood pressure ≥ 130/≥ 85 2. Systolic BP ≥ 130 or diastolic BP ≥ 85 or 
treatment for hypertension
2. Systolic BP ≥ 130 and/or diastolic BP ≥ 85 or 
treatment for hypertension
3. Triglycerides ≥ 1.7 mmol/l (≥ 150 mg/dl) 3. Triglycerides ≥ 1.7 mmol/l (≥ 150 mg/dl) or 
drug treatment for elevated triglycerides
3. Triglycerides ≥ 1.7 mmol/l (≥ 150 mg/dl) or 
specific treatment
4. HDL-cholesterol <1.03 mmol/l (<40 mg/dl, 
men) or <1.29 mmol/l (<50 mg/dl, women)
4. HDL-cholesterol <1.03 mmol/l (<40 mg/dl, 
men) or <1.29 mmol/l (<50 mg/dl, women) or 
drug treatment for low HDL-cholesterol
4. HDL-cholesterol <1.03 mmol/l (<40 mg/dl, 
men) or <1.29 mmol/l (<50 mg/dl, women) or 
specific treatment
5. Waist circumference >102 cm (men), >88 
cm (women)
5. Waist circumference ≥ 102 cm (men), ≥ 88 
cm (women)BMC Public Health 2008, 8:403 http://www.biomedcentral.com/1471-2458/8/403
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Blood pressure and diabetes
Mean blood pressure levels and prevalence of hyperten-
sion as well as treatment for hypertension are summarised
in Table 4. In general, physician measurement of blood
pressure (after breakfast) was higher than the automatic
blood pressure measurements (before breakfast by a
nurse), except for the diastolic blood pressure in 50-year-
old women. Hypertension was observed in one third of
the women aged 50 years, almost half of the men aged 50
years and two third of the men aged 60 years. Known dia-
betes (Table 4) was most common among the 60-year-old
men (6.4%) and more common among the 50-year-old
men (4.0%) than among the 50-year-old women (2.0%).
The prevalence of increased fasting plasma glucose varied
between 4 and 33% depending on age, gender, and which
cut-off level was employed (Table 4).
Lifestyle habits (smoking, snuff, coffee, alcohol, stress, and 
physical exercise)
Smoking (Table 2) was more common among the 50-
year-old women (26%) than among the 50-year-old men
(22%) and the 60-year-old men (15%). Snuff (wet
tobacco) was used by 19% of the 50-year-old men and by
17% of the 60-year-old men but by only 3% of the
women. Coffee drinking was extremely common: 89–
97% of the participants proved to be a daily coffee
drinker, with coffee drinking most common among the
60-year-old men. Perceived continuous stress (grade 4
and 5, Table 2) was more common among the women
(23%) than among the men (17% among the 50-year-old
men and 10% among the 60-year-old men). Regular phys-
ical exercise (grade 3–4, see examination procedures) was
remarkably similar (24%, in the three cohorts).
Table 2: Demographic data, self reported diseases, family history, and life style habits (%).
Men
born in 1953
Women
born in 1953
Men
born in 1943
50 years old 50 years old 60 years old
n = 595 n = 667 n = 655
Demographics
Married/cohabiting 71.6 62.5 76.2
Divorced 13.5 19.7 11.2
University/college 35.4 42.5 28.1
Workinga 82.2 72.8 65.5
Retired 4.7 8.6 16.8
Self-employed 21.4 6.5 23.1
Born in Sweden 77.0 76.7 84.4
Born in Europeb 12.3 17.4 12.5
Born outside Europe 10.8 5.9 3.1
Diseases and the family history
Myocardial infarction 1.2 0.5 6.7
Coronary by-pass surgery 0.8 0 3.4
Percutaneous coronary intervention 0.3 0.2 3.8
Atrial fibrillationc 1.0 (0.7) 0.2 (0.2) 4.4 (1.1)
Stroke 0 0.5 2.4
Family history of myocardial infarctiond 35.5 38.2 35.9
Family history of stroked 25.0 27.3 26.4
Family history of diabetesd 25.0 23.2 24.0
Life style habits
Regular smokers 21.5 26.1 15.1
Ex-smokers 41.0 36.3 47.8
Snuff, daily use 18.7 2.9 16.8
Ex-snuffers 15.9 2.4 9.3
Coffee daily 89.1 93.4 96.6
Continuous stresse 17.3 22.8 10.3
No physical exercise, leisure time 17.7 13.8 11.6
Physical exercise, leisure timef 23.7 23.9 23.8
aFull time or part time work bOutside Sweden cFigures within parenthesis are the frequencies of atrial fibrillation recorded at the examination dThe 
family history among fathers or mothers or siblings as reported by the participants eContinuous stress as reported by the participant during the last 
year or up to the last 5 years fRegular or intenseBMC Public Health 2008, 8:403 http://www.biomedcentral.com/1471-2458/8/403
Page 5 of 9
(page number not for citation purposes)
Lipids
Lipid levels and the prevalence of dyslipidaemia using dif-
ferent cut-off levels are listed in Table 5. Mean values of
cholesterol were strikingly similar (5.4–5.5 mmol/l) in
the three cohorts though women had higher HDL choles-
terol levels and lower triglyceride levels than men. Only a
minority (3–5%) of the men and women had desirable
cholesterol levels, i.e. below 4.0 mmol/l. The prevalence
of dyslipidaemia varied greatly depending on the cut-off
levels used. Drug treatment for hyperlipidaemia (mainly
for hypercholesterolaemia) was uncommon among the
50-year-olds (3–4%) compared with the 60-year-old men
(14.5%). Only 2–4% of the participants reported that
they were on diet solely because of increased lipid levels.
The metabolic syndrome
Three definitions for MetSyn were used for the popula-
tions in this study: the NCEP 2001 [12], the AHA 2005 [6]
and the IDF 2005 [13] (Table 1). We followed the defini-
tions exactly, i.e. the NCEP definition does not include
treatment for hypertension while the other two defini-
tions include that. The WHO definition [11] was not used
because we did not measure microalbuminuria and insu-
lin resistance. Blood pressure levels, which were measured
Table 3: Anthropometric data (means and standard deviation) and cut-off levels for body mass index (BMI), waist circumference and 
waist/hip ratio.
Variable Men
born in 1953
50 years old
n = 595
Women
born in 1953
50 years old
n = 667
Men
born in 1943
60 years old
n = 655
Height (cm) 179 (7) 166 (7) 178 (7)
Weight (kg) 85.6 (13.3) 70.5 (13.0) 86.3 (12.9)
BMI (kg/m2) 26.6 (3.7) 25.6 (4.5) 27.1 (3.7)
Waist (cm) 94.5 (9.9) 83.1 (11.4) 97.0 (10.0)
Hip (cm) 101.3 (6.6) 99.7 (9.1) 102.0 (6.5)
Waist/hip ratio 0.93 (0.06) 0.83 (0.07) 0.95 (0.06)
BMI ≥ 25 (%) 63.4 45.9 71.6
BMI ≥ 30 (%) 15.3 15.1 16.6
Waist ≥ 80 cm (%) 95.1 56.1 98.2
Waist ≥ 88 cm (%) 76.6 29.8 84.0
Waist ≥ 94 cm (%) 51.3 16.5 60.5
Waist ≥ 102 cm (%) 21.7 7.2 29.8
Waist/hip ratio >0.85 (%) 91.9 37.6 95.9
Waist/hip ratio >0.90 (%) 72.6 15.0 78.8
Table 4: Blood pressure levels (means and standard deviation), the prevalence of hypertension and drug treatment for hypertension.  
Prevalence of diabetes and increased fasting plasma glucose.
Variable Men
born in 1953
50 years old
n = 595
Women
born in 1953
50 years old
n = 667
Men
born in 1943
60 years old
n = 655
SBP, mm Hg, automatic 129.3 (17.8) 123.1 (19.0) 139.8 (21.0)
SBP, mm Hg, physician 134.7 (17.6) 130.7 (18.6) 143.8 (19.6)
DBP, mm Hg, automatic 83.9 (10.9) 82.6 (10.8) 85.1 (11.3)
DBP, mm Hg, physician 84.9 (10.4) 80.8 (10.2) 85.2 (10.5)
Drugs for hypertension (%) 7.1 9.6 22.5
Hypertension (%) 46.2 36.0 66.7
Known diabetes (%) 4.0 2.0 6.4
Fp-glucose ≥ 6.1 mmol/l (%) 10.2 4.2 17.0
Fp-glucose ≥ 5.6 mmol/l (%) 26.1 10.4 32.6
SBP = systolic blood pressure. DBP = diastolic blood pressure phase 5. Hypertension was defined as a physicians diagnosis of hypertension and/or 
SBP ≥ 140 and/or DBP ≥ 90 (physician measurement), and/or treatment for hypertension.
Fp = fasting, plasma. Fp-glucos ≥ 6.1 and ≥ 5.6 respectively includes those with known diabetes.
To convert p-glucose from mmol/l to mg/dl multiply by 18.
Known diabetes = those who have been told by their doctors that they have diabetesBMC Public Health 2008, 8:403 http://www.biomedcentral.com/1471-2458/8/403
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Table 5: Lipids (means and standard deviation) and prevalence of hyperlipidaemia/dyslipidaemia using various cut-off points.  
Treatment for hyperlipidaemia.
Variable Men
born in 1953
50 years old
n = 595
Women
born in 1953
50 years old
n = 667
Men
born in 1943
60 years old
n = 655
S-cholesterol mmol/l 5.50 (1.01) 5.44 (0.93) 5.38 (0.93)
HDL-cholesterol mmol/l 1.45 (0.38) 1.85 (0.45) 1.52 (0.39)
LDL-cholesterol mmol/l 3.31 (0.87) 3.05 (0.88) 3.18 (0.83)
S-triglycerides mmol/l 1.71 (1.18) 1.24 (1.14) 1.54 (0.92)
S-cholesterol <4.0 (%) 4.7 2.9 5.1
S-cholesterol ≥ 5.0 (%) 69.4 69.5 67.1
S-cholesterol ≥ 6.0 (%) 32.4 24.6 26.0
HDL-cholesterol ≤ 1.0 (%) 11.8 1.4 8.0
HDL-cholesterol ≥ 1.6 (%) 34.1 73.4 40.4
LDL-cholesterol ≤ 2.0 (%) 6.9 11.5 8.6
LDL-cholesterol ≥ 4.0 (%) 22.8 14.2 18.7
S-triglycerides ≥ 1.7 (%) 38.2 17.3 22.4
Treatment, drugs (%) 3.9 2.9 14.5
Treatment, diet only (%) 2.2 2.4 4.1
S = serum. HDL = high-density lipoprotein. LDL = low-density lipoprotein.
To convert cholesterol from mmo/l to mg/dl multiply by 38.7.
To convert triglycerides from mmol/l to mg/dl multiply by 88.6
Prevalence (%) of the metabolic syndrome using three definitions Figure 1
Prevalence (%) of the metabolic syndrome using three definitions.
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automatically, were used for the cut-off levels (≥ 130/85).
The prevalence of the MetSyn (Figure 1) increased from
10.5 to 15.8% among the 50-year-old women, from 16.1
to 26% among the 50-year-old men and from 19.9 to 35%
among the 60-year-old men depending on which defini-
tion was selected. The figures were always lowest with the
NCEP definition and highest with the IDF definition.
Number of risk factors
The following definitions of five risk factors were used:
Smokers were persons who smoked or had quit smoking
less than one month before they mailed the question-
naire. Hypertension/high blood pressure was defined as a
physician's diagnosis of hypertension and/or systolic
blood pressure (physician measurement) ≥ 130 mm Hg
and/or diastolic blood pressure ≥ 85 mm Hg, i.e. the levels
used for all three definitions of the metabolic syndrome
(Table 1). Dyslipidaemia was defined as S-cholesterol ≥
5.2 mmol/l and/or HDL cholesterol ≤ 1.03 mmol/l for
men and ≤ 1.29 mmol/l for women (IDF, Table 1) and/or
drug treatment for hyperlipidemia. Obesity was defined as
BMI ≥ 30 and/or waist circumference ≥ 94 cm for men
and/or ≥ 80 cm for women (IDF, Table 1). Impaired glu-
cose tolerance was defined as known diabetes and/or fast-
ing plasma glucose ≥ 5.6 mmol/l (AHA and IDF, Table 1).
When adding these risk factors together, very few of the
participants showed zero risk factors (overall only 5%,
Figure 2). In the separate cohorts 9% of the 50-year-old
women, 5% of the 50-year-old men and 2% of the 60-
year-old men had no risk factors. Furthermore, very few
showed evidence of all five risk factors: 2% among the 50-
year-old women, 3% among the 50-year-old men and 4%
among the 60-year-old men. Most of the participants had
2–3 risk factors (56% of the 50-year-old women, 61% of
the 50-year-old men and 60% of the 60-year-old men.
Discussion
The present study investigated the prevalence of cardio-
vascular risk factors in random samples of middle-aged
Swedish men and women examined in the beginning of
the 21st century. Using recent definitions of desirable lev-
els, very few (2–9%) of the participants presented no risk
factors at all. Moreover, we found that the prevalence of
the MetSyn varies substantially depending on which defi-
nition is used. More precisely Metsyn varied from 11 to
16% among 50-year-old women, from 16 to 26% among
50-year-old men and from 20 to 35% among 60-year-old
men.
The frequency distribution (%) in relation to number of risk factors (smoking, hypertension, dyslipidaemia, obesity and  increased fasting blood glucose/diabetes) in the three cohorts Figure 2
The frequency distribution (%) in relation to number of risk factors (smoking, hypertension, dyslipidaemia, 
obesity and increased fasting blood glucose/diabetes) in the three cohorts.
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There are two limitations that need to be acknowledged
and addressed regarding the present study. The first limi-
tation concerns that our study used a cross-sectional
design and thus the predictive value of the MetSyn for the
development of cardiovascular disease and diabetes can-
not be determined because we do not yet have follow-up
data. Another limitation is that our populations were not
representative of the general population because only two
thirds of those invited actually participated. In the first
study of 50-year-old men in Gothenburg in 1963 the par-
ticipation rate was 88% [2]. In later population studies in
Gothenburg the participation rate dropped to 76% in
1983 [5] and to 65–69% in the GOT-MONICA project in
1995 [14]. It is known that mortality is higher among
non-participants than among participants in the Gothen-
burg population studies [15,16]. Analyses of non-partici-
pants in other population studies are almost non-existent.
Smoking among 50-year-old men has decreased from
56% in 1963 to 22% in the present study. Twenty-two per-
cent is among the lowest rates reported in developed
countries [17]. Among the 50-year-old women, 26% were
smokers. This percent value could be compared with the
final survey of the international MONICA study [17]
where smoking rates among women were lowest in
Lithuania (5%) and highest in Denmark (42%).
The mean serum cholesterol level of 5.4–5.5 mmol/l in
our study ranked in the middle between the lowest (4.5
mmol/l in China) and the highest level (6.3–6.6 mmol/l
in Switzerland) in the MONICA study [17]. The higher
HDL cholesterol level in our study versus the previous
Gothenburg studies [14] may be explained by methodo-
logical differences (see Methods) as well as by a higher
level of physical activity of the cohorts in our study. In our
cohorts 24% had regular or intense physical exercise dur-
ing leisure time, whereas in the previous Gothenburg
cohorts (using the same methodology as in our study)
from 1985–1995 [14] the figures were 8–11% for women
aged 45–54 years, 13–23% for men aged 45–54 years, and
12–19% for men aged 55–64 years. In comparison with
the previous Gothenburg cohorts, the prevalence of obes-
ity, as measured by BMI, has increased slightly among the
participants in our study [14].
Using cut points for cardiovascular risk factors as
described in the IDF definition of the MetSyn [13],
together with smoking and cholesterol ≥ 5.2 mmol/l (≥
200 mg/dl) very few (2–9%) of the participants had no
risk factors at all. In the recent Swedish INTERGENE study
[18] 10% of the men and 13% of the women had "opti-
mal" risk factor status. The Norwegian HUNT study [19]
reported similar findings. The researchers of the HUNT
study concluded that if the 2003 European guidelines on
prevention of cardiovascular diseases are implemented,
most Norwegians (which they stated to be one of the
healthiest populations in the world) would be classified
as at high risk for fatal cardiovascular disease [20].
Using different definitions of the MetSyn the prevalence
of the MetSyn was found to vary (as expected) in our study
as well as in two German studies [21,22] and one Greek
study [23], although the figures were higher in the Ger-
man studies than in our study when comparing similar
age cohorts. The German GEMCAS study [22], however,
was not a strict population study but participants were
those who visited general practitioners. Even Norwegians
have a slightly higher prevalence of the MetSyn [20] using
the AHA [6] and the IDF [13] definitions than the men
and women of similar ages in our study. In Western soci-
eties the MetSyn is more common in men than in women,
but in a Chinese [24] and an Arab population [25] it was
more common in women than in men.
Especially after the introduction of the IDF definition [13]
of the MetSyn, there has been an ongoing debate about its
usefulness in clinical practice and as a predictor of cardio-
vascular disease and diabetes [26,27]. It has also been sug-
gested that the syndrome should be dumped entirely [28].
Recently, it was reported that the MetSyn (NCEP criterion)
was negligibly linked to incident vascular disease in the
elderly [29]. Fasting blood glucose alone was a better pre-
dictor of incident diabetes than the MetSyn [29]. In an
accompanying editorial [30], the clinical usefulness of the
syndrome was questioned. However, another Swedish
study [31] concluded that the MetSyn predicts cardiovas-
cular mortality in 50-year-old men, even when taking
established risk factors (e.g., smoking and elevated choles-
terol) into account.
Conclusion
This study provides up-to-date information about the
prevalence of cardiovascular risk factors and the MetSyn
in middle-aged Swedish men and women. Our study
reveals that risk factor status has improved, especially
regarding smoking. The prevalence of smoking, at least in
men, is among the lowest in the world. Based on our find-
ings and those from other studies, the usefulness of the
MetSyn is suspect, primarily because it creates uncertainty
about which definition to use.
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